Bullish
CVRx, Inc. (NASDAQ:CVRX) Q1 2026 Earnings Call Transcript
CVRx, Inc. reported a strong start to 2026, exceeding revenue guidance with 20% total revenue growth and 22% U.S. growth, driven by investments made i...
Bullish
CVRx, Inc. reported a strong start to 2026, exceeding revenue guidance with 20% total revenue growth and 22% U.S. growth, driven by investments made i...
Neutral
CVRx, Inc. (NASDAQ:CVRX) has received an average "Moderate Buy" rating from analysts, with a 1-year average price target of $10.50, despite missing re...
Bullish
Lawnwood Medical Center, in collaboration with Dr. Philip Seibel, has successfully completed its 15th Barostim implant, a therapy by CVRx. This milest...